Cargando…

Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria

BACKGROUND: The Baveno VI criteria for predicting esophageal varices, i.e., liver stiffness measurement (LSM) < 20 kPa and platelet (PLT) count > 150 × 10(9)/L, identify patients who can safely avoid gastroscopy screening. However, they require further refinement. AIM: To evaluate the utility...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Hong, Long, Jun, Hu, Han, Tian, Cai-Yun, Lin, Shi-De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761236/
https://www.ncbi.nlm.nih.gov/pubmed/31558876
http://dx.doi.org/10.3748/wjg.v25.i35.5323
_version_ 1783453985231863808
author Zhou, Hong
Long, Jun
Hu, Han
Tian, Cai-Yun
Lin, Shi-De
author_facet Zhou, Hong
Long, Jun
Hu, Han
Tian, Cai-Yun
Lin, Shi-De
author_sort Zhou, Hong
collection PubMed
description BACKGROUND: The Baveno VI criteria for predicting esophageal varices, i.e., liver stiffness measurement (LSM) < 20 kPa and platelet (PLT) count > 150 × 10(9)/L, identify patients who can safely avoid gastroscopy screening. However, they require further refinement. AIM: To evaluate the utility of LSM and serum markers of liver fibrosis in ruling out high-risk varices (HRV) in patients who do not meet Baveno VI criteria. METHODS: Data from 132 patients with hepatitis B virus (HBV)-related compensated liver cirrhosis who did not meet the Baveno VI criteria were retrospectively reviewed. MedCalc 15.8 was used to calculate receiver operating characteristic (ROC) curves, and the accuracy of LSM, PLT count, aspartate aminotransferase (AST)-to-PLT ratio index, Fibrosis-4, and the Lok index in predicting HRV were evaluated according to the area under each ROC curve (AUROC). The utility of LSM, PLT, and serum markers of liver fibrosis stratified by alanine transaminase (ALT) and total bilirubin (TBil) levels was evaluated for ruling out HRV. RESULTS: In all patients who did not meet the Baveno VI criteria, the independent risk factors for HRV were LSM and ALT. Only the AUROC of Lok index was above 0.7 for predicting HRV, and at a cutoff value of 0.4531 it could further spare 24.2% of gastroscopies without missing HRVs. The prevalence of HRV was significantly lower in patients with ALT or TBil ≥ 2 upper limit of normal (ULN) (14.3%) than in patients with both ALT and TBil < 2 ULN (34.1%) (P = 0.018). In the 41 patients with ALT and TBil < 2 ULN, LSM had an AUROC for predicting HRV of 0.821. LSM < 20.6 kPa spared 39.0% of gastroscopies without missing HRVs. In the 91 patients with ALT or TBiL ≥ 2 ULN, the Lok index and PLT had AUROCs of 0.814 and 0.741, respectively. Lok index ≤ 0.5596 or PLT > 100 × 10(9)/L further spared 39.6% and 43.9% of gastroscopies, respectively, without missing HRVs. CONCLUSION: In HBV-related compensated cirrhosis patients who do not meet Baveno VI criteria, the LSM, PLT, or Lok index cutoff stratified by ALT and TBil accurately identifies more patients without HRV.
format Online
Article
Text
id pubmed-6761236
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-67612362019-09-26 Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria Zhou, Hong Long, Jun Hu, Han Tian, Cai-Yun Lin, Shi-De World J Gastroenterol Case Control Study BACKGROUND: The Baveno VI criteria for predicting esophageal varices, i.e., liver stiffness measurement (LSM) < 20 kPa and platelet (PLT) count > 150 × 10(9)/L, identify patients who can safely avoid gastroscopy screening. However, they require further refinement. AIM: To evaluate the utility of LSM and serum markers of liver fibrosis in ruling out high-risk varices (HRV) in patients who do not meet Baveno VI criteria. METHODS: Data from 132 patients with hepatitis B virus (HBV)-related compensated liver cirrhosis who did not meet the Baveno VI criteria were retrospectively reviewed. MedCalc 15.8 was used to calculate receiver operating characteristic (ROC) curves, and the accuracy of LSM, PLT count, aspartate aminotransferase (AST)-to-PLT ratio index, Fibrosis-4, and the Lok index in predicting HRV were evaluated according to the area under each ROC curve (AUROC). The utility of LSM, PLT, and serum markers of liver fibrosis stratified by alanine transaminase (ALT) and total bilirubin (TBil) levels was evaluated for ruling out HRV. RESULTS: In all patients who did not meet the Baveno VI criteria, the independent risk factors for HRV were LSM and ALT. Only the AUROC of Lok index was above 0.7 for predicting HRV, and at a cutoff value of 0.4531 it could further spare 24.2% of gastroscopies without missing HRVs. The prevalence of HRV was significantly lower in patients with ALT or TBil ≥ 2 upper limit of normal (ULN) (14.3%) than in patients with both ALT and TBil < 2 ULN (34.1%) (P = 0.018). In the 41 patients with ALT and TBil < 2 ULN, LSM had an AUROC for predicting HRV of 0.821. LSM < 20.6 kPa spared 39.0% of gastroscopies without missing HRVs. In the 91 patients with ALT or TBiL ≥ 2 ULN, the Lok index and PLT had AUROCs of 0.814 and 0.741, respectively. Lok index ≤ 0.5596 or PLT > 100 × 10(9)/L further spared 39.6% and 43.9% of gastroscopies, respectively, without missing HRVs. CONCLUSION: In HBV-related compensated cirrhosis patients who do not meet Baveno VI criteria, the LSM, PLT, or Lok index cutoff stratified by ALT and TBil accurately identifies more patients without HRV. Baishideng Publishing Group Inc 2019-09-21 2019-09-21 /pmc/articles/PMC6761236/ /pubmed/31558876 http://dx.doi.org/10.3748/wjg.v25.i35.5323 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Case Control Study
Zhou, Hong
Long, Jun
Hu, Han
Tian, Cai-Yun
Lin, Shi-De
Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria
title Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria
title_full Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria
title_fullStr Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria
title_full_unstemmed Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria
title_short Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria
title_sort liver stiffness and serum markers for excluding high-risk varices in patients who do not meet baveno vi criteria
topic Case Control Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761236/
https://www.ncbi.nlm.nih.gov/pubmed/31558876
http://dx.doi.org/10.3748/wjg.v25.i35.5323
work_keys_str_mv AT zhouhong liverstiffnessandserummarkersforexcludinghighriskvaricesinpatientswhodonotmeetbavenovicriteria
AT longjun liverstiffnessandserummarkersforexcludinghighriskvaricesinpatientswhodonotmeetbavenovicriteria
AT huhan liverstiffnessandserummarkersforexcludinghighriskvaricesinpatientswhodonotmeetbavenovicriteria
AT tiancaiyun liverstiffnessandserummarkersforexcludinghighriskvaricesinpatientswhodonotmeetbavenovicriteria
AT linshide liverstiffnessandserummarkersforexcludinghighriskvaricesinpatientswhodonotmeetbavenovicriteria